[go: up one dir, main page]

TN2011000089A1 - Compounds for the treatment of hepatitis c - Google Patents

Compounds for the treatment of hepatitis c

Info

Publication number
TN2011000089A1
TN2011000089A1 TN2011000089A TN2011000089A TN2011000089A1 TN 2011000089 A1 TN2011000089 A1 TN 2011000089A1 TN 2011000089 A TN2011000089 A TN 2011000089A TN 2011000089 A TN2011000089 A TN 2011000089A TN 2011000089 A1 TN2011000089 A1 TN 2011000089A1
Authority
TN
Tunisia
Prior art keywords
compounds
hepatitis
treatment
hcv
virus
Prior art date
Application number
TN2011000089A
Other languages
French (fr)
Inventor
Kap Sun Yeung
Kyle E Parcella
John A Bender
Brett R Beno
Katharine A Grant-Young
Ying Han
Piyasena Hewawasam
John F Kadow
Andrew Nickel
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2009/056166 external-priority patent/WO2010030592A1/en
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of TN2011000089A1 publication Critical patent/TN2011000089A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The disclosure provides compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.
TN2011000089A 2009-09-08 2011-02-22 Compounds for the treatment of hepatitis c TN2011000089A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2009/056166 WO2010030592A1 (en) 2008-09-11 2009-09-08 Compounds for the treatment of hepatitis c

Publications (1)

Publication Number Publication Date
TN2011000089A1 true TN2011000089A1 (en) 2012-09-05

Family

ID=55024388

Family Applications (1)

Application Number Title Priority Date Filing Date
TN2011000089A TN2011000089A1 (en) 2009-09-08 2011-02-22 Compounds for the treatment of hepatitis c

Country Status (1)

Country Link
TN (1) TN2011000089A1 (en)

Similar Documents

Publication Publication Date Title
MX2012004032A (en) Compounds for the treatment of hepatitis c.
WO2010030538A3 (en) Compounds for the treatment of hepatitis c
EA201100390A1 (en) CONNECTIONS FOR THE TREATMENT OF HEPATITIS C
MX2009009473A (en) Compounds for the treatment of hepatitis c.
MX2012000959A (en) Inhibitors of flaviviridae viruses.
MX2010001416A (en) Compounds for the treatment of hepatitis c.
MX2010008531A (en) Conformationally restricted biphenyl derivatives for use as hepatitis c virus inhibitors.
MX2012008221A (en) Inhibitors of flaviviridae viruses.
MX2012008211A (en) Inhibitors of flaviviridae viruses.
NZ595186A (en) Di-pyrazolidinyl-biphenylyl compounds for treating hepatitis C virus (HCV) infection
MX2013006475A (en) Macrocyclic inhibitors of flaviviridae viruses.
TN2012000264A1 (en) Hepatitis c virus inhibitors
TN2012000214A1 (en) Hepatitis c virus inhibitors
MX2010008749A (en) Hepatitis c virus inhibitors.
MX2011008045A (en) Hepatitis c virus inhibitors.
SI1987038T1 (en) Hcv ns5b inhibitors
MX2010008699A (en) Heterocyclic derivatives as hepatitis c virus inhibitors.
IN2012DN01855A (en)
PH12013501543A1 (en) Hepatitis c virus inhibitors
SI2209789T1 (en) Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors
MX337936B (en) Hepatitis c virus inhibitors.
ATE551343T1 (en) TETRACYCLIC COMPOUNDS FOR THE TREATMENT OF HEPATITIS C
DE602008004317D1 (en) COMPOUNDS FOR THE TREATMENT OF HEPATITIS C
PH12013502177A1 (en) Hepatitis c virus inhibitors
ATE505473T1 (en) CYCLOPROPYL-CONDENSED INDOLOBENZAZEPINE DERIVATIVES FOR THE TREATMENT OF HEPATITIS C